A XM não fornece serviços a residentes nos Estados Unidos da América.

Temasek portfolio value logs modest rise; has a cautious approach to China



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Temasek portfolio value logs modest rise; has a cautious approach to China</title></head><body>

By Yantoultra Ngui

SINGAPORE, July 9 (Reuters) -Singapore state investor Temasek said on Tuesday its net portfolio value had swung back to growth with a 1.8% gain, adding that profits from investments in the United States and India helped cushion the impact of underperformance in China.

Significantly, Temasek's TEM.UL exposure to the Americas surpassed China for the first time in a decade, accounting for 22% of its portfolio versus China's 19% during the year ended March.

Temasek said it is taking a cautious approach to China and would continue to monitor the country's government policies this year. Aside from Singapore - its biggest market accounting for 27% of its portfolio, the U.S. would continue to be a leading destination for its capital, followed by India and Europe.

The firm added it plans to step up investments in Japan and Southeast Asia. Temasek is also considering building its presence in the Middle East, Deputy CEO Chia Song Hwee told Reuters in an interview.

"The economies (in the Middle East) are going through transformation and opening up and also the policy directions are more investor friendly as well as market-driven," he said.

"So we are clearly seeing the change and we are beginning to spend time looking at opportunities and evaluating."

The rise in the value of Temasek's portfolio to S$389 billion ($288.5 billion) compares with last year's 5.2% drop which had marked the first decline since 2020 amid global economic uncertainties and a higher interest rate environment.

Chia said the firm would continue to "reshape" its portfolio. That includes in China where geopolitical tensions remain a concern and focusing on companies that are centred on the domestic market and rely less on exports, he said.

"Portfolio never stays static. And what we try to do is to reshape our portfolio time and time again to be future-proof, future-ready while making sure that we can earn a long-term sustainable return," he added.

"Our portfolio is still very large in China, even at 19% it is still a large portfolio for us."

Chinese companies that Temasek has invested in include Alibaba Group 9988.HK and Tencent Holdings 0700.HK, owning stakes of less than 1% in both. It also invested in Chinese electric vehicle company BYD 1211.HK during the latest financial year. The size of that holding was not disclosed.

In the United States, its investments include its stake of around 3% in asset manager BlackRock BLK.N and holdings of less than 1% in credit card payment companies Visa V.N and Mastercard MA.N.

Regardless of the outcome of the U.S. election in November, the world's largest economy will continue to be an "interesting market" for Temasek due to innovation and opportunities in the private credit and technology sectors, Chief Financial Officer Png Chin Yee said in a separate interview.

Temasek will continue to seek investment opportunities in artificial intelligence and green transition, its head of financial services Connie Chan also said.

In May, Temasek partnered with Canada's Brookfield BN.TO to invest in Neoen NEOEN.PA, a deal that valued the French renewable power producer at around 6.1 billion euros ($6.6 billion).

Other global investors have also posted gains driven by a better-than-expected U.S. economy and growing expectations of lower interest rates.

This month, Japan's Government Pension Investment Fund posted an investment gain of $133.3 billion for the January-March quarter, while Saudi Arabia's sovereign wealth fund PIF reported it swung to a profit of $36.8 billion in 2023.



($1 = 1.3484 Singapore dollars)

($1 = 0.9228 euros)



Reporting by Yantoultra Ngui; Editing by Sumeet Chatterjee and Edwina Gibbs

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.